Activity of poloxamer CRL-1072 against drug-sensitive and resistant strains of Mycobacterium tuberculosis in macrophages and in mice

International Journal of Antimicrobial Agents

Volumn 15, Issue 1, 2000, Pages 55-63

  Jagannath, Chinnaswamy ^a   Emanuele, Martin R ^a   Hunter, Robert L ^b  

^a CytRx Corporation   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CRL 1072; Drug susceptibility; Mycobacterium tuberculosis; Poloxamers; U937

Indexed keywords

AMINOSALICYLIC ACID; CRL 1072; ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; POLOXAMER; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; THIOACETAZONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERICIDAL ACTIVITY; BACTERIOSTASIS; CONTROLLED STUDY; DRUG POTENTIATION; FEMALE; HUMAN; HUMAN CELL; MACROPHAGE; MALE; MINIMUM INHIBITORY CONCENTRATION; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTITUBERCULAR AGENTS; DRUG RESISTANCE, MICROBIAL; DRUG SYNERGISM; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MYCOBACTERIUM TUBERCULOSIS; POLOXAMER;

EID: 0034091268     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(00)00118-7     Document Type: Article

References (24)

1. Cornforth J.W., Hart P., Rees R.J.W., Stock J. Antituberculous effect of certain suface active polyoxyethylene ethers in mice. Nature. 168:1951;150-153.
2. Lundsted L.G., Schmolka I.R. The synthesis and properties of block copolymer polyol surfactants. Ceresa J. Block and Graft Copolymerization. 1976;Wiley, London.
3. Schmolka I.R. A review of block polymer surfactants. J. Am. Oil Chem. Soc. 54:1977;110-116.
4. Hunter R.L., Olsen M., Buynitzky S. Adjuvant activity of non-ionic block copolymers. IV. Effect of molecular weight and formulation on titer and isotype of antibody. Vaccine. 9:1991;250-256.
5. Hunter R.L., Jagannath C., Tinkley A., Behling C.A., Nolte F. Enhancement of antibiotic sensitivity and suppression of Mycobacterium avuim complex growth by poloxamer 331. Antimicrob. Agent Chemother. 39:1995;435-439.
6. Jagannath C., Allaudeen H.S., Hunter R.L. Jr Activity of poloxamer CRL-8131 against Mycobacterium tuberculosis in vitro and in vivo. Antimicrob. Agent Chemother. 39:1995;1349-1354.
7. Sison J.P., Yao C.A., Kemper J.R., Hamilton E., Brummer D.A., Deresinski S.C. Treatment of Mycobacterium avium complex infection: do the results of in vitro susceptibility tests predict therapeutic outcome in humans? J. Infect. Dis. 173:1996;677-683.
8. Sundstrom C., Nilsson K. Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int. J. Cancer. 17:1976;565-577.
9. Berenbaum M.C. A method of testing synergy with any number of agents. J. Infect. Dis. 137:1978;122-130.
10. Heifets LB, editor. Antituberculosis drugs: antimicrobial activity in vitro. In: Drug Susceptibility in Chemotherapy of Mycobacterial Infections. Boca Raton, FL: CRC Press, 1991.
11. Jagannath C., Reddy M.V., Kailasam S., O'Sullivan J.F., Gangadharam P.R.J. Chemotherapeutic activity of clofazimine and its analogues against Mycobacterium tuberculosis. In vitro, intracellular and in vivo studies. Am. J. Respir. Crit. Care Med. 151:1995;1083-1086.
12. Jagannath C., Reddy M.V., Gangadharam P.R.J. Enhancement of drug susceptibility of multi-drug resistant strains of Mycobacterium tuberculosis by ethambutol and dimethyl sulfoxide. J. Antimicrob. Chemother. 35:1995;381-390.
13. Anonymous. Drugs for AIDS and associated infections, Drugs Ther 1995;37:87-94.
14. Heifets LB, editor. Drug combinations. In: Drug Susceptibility in Chemotherapy of Mycobacterial Infections. Boca Raton, FL: CRC Press, 1991.
15. Nikaido H. Prevention of drug access to bacterial targets: permeability barriers and active efflux. Science. 264:1994;382-388.
16. Honore N., Cole S.T. Streptomycin resistance in mycobacteria. Antimicrob. Agent Chemother. 38:1994;238-242.
17. Rastogi N., Goh K.S., David H.L. Enhancement of drug susceptibility of Mycobacterium avium by inhibitors of cell envelope synthesis. Antimicrob. Agent Chemother. 34:1990;759-764.
18. Hoffner S.E., Svenson S.B. Studies on the role of the mycobacterial cell envelope in the multiple drug resistance of atypical mycobacteria. Res. Microbiol. 142:1991;448-451.
19. Vaara M. Agents that increase the permeability of the outer membrane. Microbiol. Rev. 56:1992;395-411.
20. Jarlier V., Nikaido H. Mycobacterial cell wall: structure and role in natural resistance to antibiotics (review). FEMS Microbiol. Lett. 123:1994;11-18.
21. Jagannath et al. Activity of CRL-1072 against M. avium in vitro and in vivo. Proceedings of the 35th ICAAC, September 1995, San Francisco, CA [Abstract].
22. Hart P.D., Payne S.D. Effects of non-ionic surfactants that modify experimental tuberculosis on lipase activity of macrophages. Br. J. Pharmacol. 43:1971;190-196.
23. Hunter R.L., Strickland F., Kezdy F. The adjuvant activity of nonionic block polymer surfactants.I. The role of hydrophile-lipophile balance. J. Immunol. 127:1981;1244-1250.
24. Comai K., Sullivan A.C. Antiobesity activity of pluronic L-101. Int. J. Obesity. 4:1980;33-42.